Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
NCT05482880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2026-01-06
Summary
Patient reported outcomes in patients with high-risk cutaneous squamous cell carcinoma in the head-neck region are an important part of the complex care for these patients. Health-related quality of life, decision conflicts in the choice of treatment and satisfaction with care have not yet been sufficiently studied in this patient group.
Conditions
- Cutaneous Squamous Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Squamous Cell Carcinomas
- Squamous Cell Carcinoma of Head and Neck
- Squamous Cell Carcinoma of the Skin
- Squamous Cell Carcinoma of the Head and Neck
- Skin Cancer
- High-Risk Cancer
- Quality of Life
- Satisfaction, Patient
Interventions
- OTHER
-
Regular care with additionally administration of questionnaires
Patients receiving regular care. In addition, validated questionnaires are administered at two measurement points: 1. after the multidisciplinary consultation, a baseline questionnaire\*, the decision conflict scale and the EQ-5D-5L questionnaire are administered by phone. 2. 1 month after completion of the treatment program (care pathway) the EQ-5D-5L, the BaSQoL and the EORTC IN-PATSAT32 questionnaires will be administered by phone. Completing the questionnaires takes about 30 minutes each time. \*Baseline questionnaire: gender, age, marital status, education level, World Health Organization (WHO) performance status, presence of informal care, stage and treatment of cSCC, history of skin cancer, presence of current other skin cancer, and average travel time to hospital.
Sponsors & Collaborators
-
Maastricht University Medical Center
lead OTHER
Principal Investigators
-
K Mosterd, MD, PhD · Maastricht University Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-28
- Primary Completion
- 2023-11-01
- Completion
- 2024-12-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT01528163 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
NCT05123950 ·Status: COMPLETED
-
Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
NCT01452984 ·Status: COMPLETED
-
Reliability and Validity of Patient Reported Outcome Measures in Head and Neck Cancer
NCT02554968 ·Status: COMPLETED
-
Evaluation of the Efficacy and Safety of Local Cryotherapy Treatment of Recurrent Head and Neck Cancer in Irradiated Areas: a Pilot Study
NCT05738187 ·Status: RECRUITING ·Phase: NA
-
A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)
NCT05068609 ·Status: COMPLETED
-
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
NCT05929547 ·Status: NOT_YET_RECRUITING
-
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
NCT00713219 ·Status: COMPLETED ·Phase: PHASE2
-
Induction Modified TPF Followed by Concurrent Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT05527782 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
NCT03667482 ·Status: COMPLETED ·Phase: PHASE1
-
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Clinical Study of the Poorly Differentiated Head and Neck Squamous Cell Carcinoma
NCT02916368 ·Status: UNKNOWN
-
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
NCT05987579 ·Status: ACTIVE_NOT_RECRUITING
-
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
NCT00494182 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02778191 ·Status: COMPLETED
-
Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal Cancer
NCT01949740 ·Status: TERMINATED
-
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
NCT02047201 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Multimodality Treatment on Physical Functions and Quality of Life in Patients With Head and Neck Cancer
NCT05036902 ·Status: COMPLETED
-
Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada
NCT02705833 ·Status: COMPLETED
-
A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
NCT00483821 ·Status: COMPLETED
-
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
NCT03837613 ·Status: UNKNOWN
-
A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck
NCT02054442 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Dose De-escalation and Sentinel LN Mapping Driven Radiotherapy of Contralateral Neck in Ipsilateral Node Positive HNSCC
NCT04688528 ·Status: RECRUITING ·Phase: NA
-
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
NCT05494190 ·Status: RECRUITING ·Phase: NA
-
Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery
NCT01280318 ·Status: COMPLETED ·Phase: PHASE1/PHASE2